Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
BIO
BIO
NYSE
Health Technology
Medical Specialties
305.96
USD
+4.26
+1.41%
Kapalı: 07-22 20:00 (UTC+0)
305.96
USD
+1.34
+0.44%
Piyasa öncesi: 07-23 08:26 (UTC+0)

BIO Temel İstatistikler

YÜKSEK
307.10
Açık
301.00
Hacim
275.06K
Düşük
298.74
Önceki Kapanış
301.70
İşlem Değeri
84.03M
52H En Yüksek
343.12
Göreceli Hacim
0.897
Dalgalanma (%)
2.77%
52H En Düşük
236.73
Devir Oranı
1.27%
Piyasa Değeri
8.18B
F/K (TTM)
50.37
F/K (Yıllık)
10.978
GD/DD
1.2
F/S
3.16
Hisse Başına Kazanç (EPS)
6.075
Temettü (TTM)
0
Temettü Verimi
0.00%
Dolaşımdaki hisseler
21.70M
Para Birimi
USD

BIO Fiyat Performansı

7 gün
30 gün
90 gün
180 gün
Yıl başından bugüne
1 Yıl
BIO Para Akışı Dağılımı
BIO Günlük Açığa Satış Hacmi
BIO Short Interest Geçmişi
As of 2026-07-23, the Bio-Rad Laboratories, Inc. (BIO) stock price today is 305.96. Based on this price, the company has a market capitalization of $8.18B, with a P/E ratio of 50.37. On 2026-07-23, BIO traded between 298.74 and 307.10. Today’s stock price is 2.42% above the daily low and 0.37% below the daily high, placing BIO üst seviyesine yakın its most recent trading range. Trading volume currently stands at 275.06K, compared with an average daily volume of 306.76K. This suggests that trading activity is olağan seviyesiyle kabaca uyumlu than usual. Over the past year, Bio-Rad Laboratories, Inc. shares have traded between 236.73 and 343.12. At today’s price, BIO is 29.24% above its 52-week low and 10.83% below its 52-week high.
Şirket adı
Bio-Rad Laboratories, Inc.
Sektör
Health Technology
Endüstri
Medical Specialties
Borsalar
NYSE
Çalışan Sayısı
7,450
Lot Büyüklüğü
40
Resmî web sitesi
Para Birimi
USD
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

BIO FAQ

Ara
Daha fazla